Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pediatr Blood Cancer. 2015 Nov 3;63(3):527–534. doi: 10.1002/pbc.25804

TABLE II.

Assessment of intelligence and neurocognitive function

Measure (n) Hearing Loss1 No Hearing
Loss1
N (%) Mean±SE Mean±SE p2
Full Scale IQ 47 (81) 85±3.2 93±2.7 0.038
Verbal Comprehension Index 47 (81) 88±3.3 95±3.1 0.082
  Similarities or Word Reasoning 50 (86) 8.6±0.7 10.0±0.7 0.048
  Vocabulary/ Receptive Vocabulary 53 (91) 6.6±0.6 8.2±0.6 0.039
  Comprehension/Information Subtest 35 (60) 7.0±0.9 8.9±0.7 0.057
Perceptual Reasoning Index/Performance 50 (86) 88±2.6 100±2.7 0.003
  Block Design 53 (91) 7.5±0.5 9.3±0.6 0.011
  Picture Concepts, Visual Puzzle, Object assembly 28 (48) 9.1±1.0 10.5±0.5 0.149
  Matrix Reasoning 42 (72) 9.0±0.6 10.5±0.7 0.048
Working Memory Index 38 (66) 84±2.8 95±2.7 0.003
  Digit Span3 42 (72) 6.9±0.5 9.5±0.6 <0.001
  L-N Sequence/ Arithmetic 27 (47) 7.4±0.7 8.6±0.5 0.138
Processing Speed Index4 46 (79) 78±4.3 85±2.8 0.126
  Coding 47 (81) 5.8±0.6 7.1±0.6 0.059
  Symbol Search 46 (79) 6.5±0.7 7.7±0.6 0.044
Visual Motor Integration 23 (40) 72±4.8 92±5.6 0.102
1

Significant hearing loss defined as Chang Grade ≥2b.

2

Wilcoxon or unpaired 1-tailed t-test, significance set at α<0.05 (bolded).

3

Digit span forward and digit span backward compared with no significant differences.

4

One subject recorded a “0,” analysis run above as lowest reportable value (40), repeated as “0” with no significant change in results.

L-N Sequence = Letter-Number Sequencing.